Proof of Usefulness Report

Ebenbuild

Analysis completed on 2/14/2026

+72
Proof of Usefulness Score
You're In Business

Ebenbuild is a verifiable, high-potential deep-tech startup emerging from TU Munich, specializing in 'digital twin' lung simulations for ARDS treatment and drug development. The project demonstrates exceptional Real-World Utility and Technical Innovation, backed by significant external validation (EIC Accelerator grant, seed funding). However, the submission itself is of extremely poor quality, containing demonstrable falsehoods (claiming 'most people' have used the product and 'everyone' is the audience) and inaccurate data (team size exaggerated, revenue field confused with market cap). Consequently, the score is heavily penalized for lack of credible provided evidence and poor response quality, despite the underlying technology's legitimacy.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+23.75
Audience Reach Impact+4.00
Technical Innovation+14.25
Evidence Of Traction+10.00
Market Timing Relevance+9.00
Functional Completeness+0.25
Subtotal+61.25
Usefulness Multiplierx1.18
Final Score+72

Project Details

Project URL
ebenbuild.com
Description
Ebenbuild is a digital health tech pioneer developing precise, patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. Its digital toolset is based on physics-based simulation, AI, and data science and is designed to support decision makers in the life sciences industry, clinicians, and physicians. Ebenbuild's approach provides a better understanding of respiratory diseases and individual pathophysiology enabling a new class of products and services ranging from in silico trials to accelerate and de-risk the development of inhaled drugs to personalized treatment options that improve the chances of survival and recovery in millions of cases of respiratory conditions such as Acute Respiratory Distress Syndrome (ARDS) each year.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline